Toxicological perspectives of inhaled therapeutics and nanoparticles

Expert Opinion on Drug Metabolism and Toxicology

Volumn 10, Issue 7, 2014, Pages 933-947

  Hayes, Amanda J ^a   Bakand, Shahnaz ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Direct exposure methods; in vitro toxicity; Inhalation therapy; Inhalation toxicology; Nanocarriers; Nanomaterials; Nanotoxicology; Pulmonary drug delivery; Therapeutics

Indexed keywords

NANOCARRIER; NANOPARTICLE; AEROSOL;

ACUTE LUNG INJURY; AEROSOL; ASTHMA; CELL INTERACTION; CELL MEMBRANE; DOSIMETRY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; GAS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INHALATION; NONHUMAN; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE; REVIEW; TARGET CELL; TOXICOLOGY; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; LD 50; MAXIMUM TOLERATED DOSE; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY TRACT DISEASES; TOXICITY TESTING;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LETHAL DOSE 50; MAXIMUM TOLERATED DOSE; MODELS, BIOLOGICAL; NANOPARTICLES; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASES; TOXICITY TESTS;

EID: 84902487138     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2014.916276     Document Type: Review

References (129)

1. Dockery DW, Pope CA III, Xu X, et al. An association between air pollution and mortality in six US cities. N Engl J Med 1993;329(24):1753-9
2. Greenberg MI, Phillips SD. A brief history of occupational, industrial and environmental toxicology. 2nd edition. Mosby, Inc., Philadelphia, Pennsylvania; 2003
3. Klaassen CD, editor. Casarett and Doulls toxicology: the basic science of poisons. 7th edition. Mc Graw-Hill, New York; 2008
4. Winder C. Toxicology of gases, vapours and particulates. In: Winder C, Stacey NH, editors. Occupational toxicology. 2nd edition. CRC Press, Boca Raton; 2004
5. Agrawal MR, Winder C. Frequency and occurrence of LD50 values for materials in the workplace. J Appl Toxicol 1996;16(5):407-22
6. EPA. Chemical hazard availability study. Office of Pollution Prevention and Toxics, Washington DC; 1998
7. Faustman EM, Omenn GS. Risk assessment. 6th edition. McGraw-Hill, New York; 2001
8. NTP. Toxicology testing strategies to determine needs and priorities. National Research Council, Washington; 1984
9. BeruBe K, Aufderheide M, Breheny D, et al. In vitro models of inhalation toxicity and disease. The report of a FRAME workshop. Altern Lab Anim 2009;37(1):89-141
10. Arts JH, Muijser H, Jonker D, et al. Inhalation toxicity studies: OECD guidelines in relation to REACH and scientific developments. Exp Toxicol Pathol 2008;60(2-3):125-33
11. Costa DL. Alternative test methods in inhalation toxicology: challenges and opportunities. Exp Toxicol Pathol 2008;60(2-3):105-9
12. Bakand S, Hayes A, Winder C, et al. In vitro cytotoxicity testing of airborne formaldehyde collected in serum-free culture media. Toxicol Ind Health 2005;21(7-8):147-54
13. Blank F, Gehr P, Rutishauser RR. In vitro human lung cell culture models to study the toxic potential of nanoparticles. John Wily & Sons Ltd, UK; 2009
14. Lambre CR, Auftherheide M, Bolton RE, et al. In vitro tests for respiratory toxicity, The report and recommendations of ECVAM workshop18. Altern Lab Anim 1996;24:671-81
15. Hodgson E, Levi PE, Bonner JC. Respiratory toxicity. In: Hodgson E, editor. A textbook of modern toxicology. 3rd edition. Wiley Interscience, New Jersey; 2004. p. 317-27
16. Phalen RF. Inhalation studies: foundations and techniques. CRC Press, Boca Raton; 1984
17. Zhang C, Kleinstreuer C. Airflow structures and nano-particle deposition in a human upper airway model. J Comput Phys 2004;198:178-210
18. Medinsky MA, Bond JA. Sites and mechanisms for uptake of gases and vapors in the respiratory tract. Toxicology 2001;160(1-3):165-72
19. Carvalho TC, Peters JI, Williams RO III. Influence of particle size on regional lung deposition-what evidence is there? Int J Pharm 2011;406(1-2):1-10
20. Bakand S, Hayes A. Troubleshooting methods for toxicity testing of airborne chemicals in vitro. J Pharmacol Toxicol Methods 2010;61(2):76-85
21. Bakand S, Winder C, Khalil C, et al. Toxicity assessment of industrial chemicals and airborne contaminants: transition from in vivo to in vitro test methods: A review. Inhal Toxicol 2005;17(13):775-87
22. Hext PM. Inhalation toxicology. In: Ballantyne B, Marrs TC, Syversen T, editors. General and applied toxicology. 2nd edition. Macmillan reference Ltd, London; 2000. p. 587-601
23. Rozman KK, Klaassen CD. Absorption, distribution and excretion of toxicants. In: Klaassen CD, editor. Casarett and Doulls toxicology: the basic science of poisons. 6th edition. McGraw-Hill, New York; 2001. p. 105-32
24. Asgharian B, Wood R, Schlesinger RB. Empirical modeling of particle deposition in the alveolar region of the lungs: A basis for interspecies extrapolation. Fundam Appl Toxicol 1995;27(2):232-8
25. Schlesinger RB. Disposition of inhaled particles and gases. In: Cohen MD, Zelikoff JT, Schlesinger RB, editors. Pulmonary immunotoxicology. Kluwer Academic Publishers, Boston; 2000. p. 85-106
26. Valentine R, Kennedy JGL. Inhalation toxicology. In: Wallace Hayes A, editor. Principles and methods of toxicology. 4th edition. Taylor and Francis, Philadelphia; 2001. p. 1085-143
27. Eaton DL. Toxicology. In: Rosenstock L, Cullen MR, Brodkin CA, et al. editors. Textbook of clinical occupational and environmental medicine. Elsevier Saunders, Philadelphia; 2005. p. 83-118
28. Siegmann K, Scherrer L, Siegmann HC. Physical and chemical properties of airborne nanoscale particles and how to measure the impact on human health. J Mol Struc-Theochem 1999;458:191-201
29. Witschi HP. Toxic responses of the respiratory system. In: Klaassen CD, editor. Casarett and Doulls toxicology: the basic science of poisons. 6th edition. McGraw-Hill, New York; 2001. p. 515-34
30. William PL, Buson JL. Industrial toxicology -safety and health applications in the workplace. Van Nostard Reinhold, New York; 1985
31. Bergeron S, Archambault DP. Canadian stewardship practices for environmental nanotechnology. Science-Metrix, Canada; 2005
32. Borm PJ, Robbins D, Haubold S, et al. The potential risks of nanomaterials: A review carried out for ECETOC. Part Fibre Toxicol 2006;3:11
33. Lundborg M, Johard U, Lastbom L, et al. Human alveolar macrophage phagocytic function is impaired by aggregates of ultrafine carbon particles. Environ Res 2001;86(3):244-53
34. Mublfeld C, Gebr P, Rutishauser BR. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly 2008;138:387-91
35. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005;113(7):823-39
36. Donaldson K, Brown D, Clouter A, et al. The pulmonary toxicology of ultrafine particles. J Aerosol Med 2002;15(2):213-20
37. Asgharian B, Price O, Oberdorster G. A modeling study of the effect of gravity on airflow distribution and particle deposition in the lung. Inhal Toxicol 2006;18(7):473-81
38. Eaton DL, Klaassen CD. Principles of toxicology. In: Klaassen CD, editor. Casarett and Doulls toxicology -The basic science of poisons. 5th edition. McGraw-Hill, USA; 1996
39. David A, Wagner GR. Respiratory system. In: Stellman JM, editor. Encyclopaedia of occupational health and safety. 4th edition. International Labour Office, Geneva; 1998. p. 10.1-7
40. Winder C. Occupational respiratory diseases. In: Winder C, Stacey NH, editors. Occupational toxicology. CRC Press, Boca Raton; 2004. p. 71-114
41. Frampton MW. Systemic and cardiovascular effects of airway injury and inflammation: ultrafine particle exposure in humans. Environ Health Perspect 2001;109(Suppl 4):529-32
42. Nawrot TS, Alfaro-Moreno E, Nemery B. Update in occupational and environmental respiratory disease 2007. Am J Respir Crit Care Med 2008;177(7):696-700
43. Pope CA III, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002;287(9):1132-41
44. Ruckerl R, Schneider A, Breitner S, et al. Health effects of particulate air pollution: A review of epidemiological evidence. Inhal Toxicol 2011;23(10):555-92
45. Hendrick DJ, Burge PS, Beckett WS, et al. Occupational disorders of the lung: recognition, management and prevention. WB Saunders, London; 2002
46. Lizarralde SM, Wake B, Thompson V, et al. Jewelers. In: Greenberg MI, Hamilton RJ, Phillips SD, et al. editors. Occupational, industrial, and environmental toxicology. 2nd edition. Mosby, Inc, Philadelphia, Pennsylvania; 2003. p. 198-215
47. Owen K. Regulatory toxicology considerations for the development of inhaled pharmaceuticals. Drug Chem Toxicol 2013;36(1):109-18
48. Shusterman D. Asphyxiation. In: Hendrick DJ, Burge PS, Beckett WS, et al. editors. Occupational disorders of the lung: recognition, management and prevention. WB Saunders, London; 2002. p. 279-303
49. Sanders M. Inhalation therapy: An historical review. Prim Care Respir J 2007;16(2):71-81
50. Thai A, Xiao J, Ammit AJ, et al. Development of inhalable formulations of anti-inflammatory drugs to potentially treat smoke inhalation injury in burn victims. Int J Pharm 2010;389(1-2): 41-52
51. Wolff RK, Dorato MA. Toxicologic testing of inhaled pharmaceutical aerosols. Crit Rev Toxicol 1993;23(4):343-69
52. Sunitha R, Suria prabha K, Muthu Prasnna P. Drug delivery and its developments for pulmonary system. Int J Pharm Chem Biol Sci 2011;1(1):66-82
53. Jones DR, Baldrick P. Association of inhalation toxicologists (AIT) review of regulatory aspects for inhalation toxicology studies. Inhal Toxicol 2013;25(2):84-90
54. DeGeorge JJ, Ahn CH, Andrews PA, et al. Considerations for toxicology studies of respiratory drug products. Regul Toxicol Pharmacol 1997;25(2):189-93
55. Beck-Broichsitter M, Merkel OM, Kissel T. Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J Control Release 2012;161(2):214-24
56. Forbes B, Asgharian B, Dailey LA, et al. Challenges in inhaled product development and opportunities for open innovation. Adv Drug Deliv Rev 2011;63(1-2):69-87
57. Siekmeier R, Scheuch G. Systemic treatment by inhalation of macromolecules -principles, problems, and examples. J Physiol Pharmacol 2008;59(Suppl 6):53-79
58. Klein CL, Wiench K, Wiemann M, et al. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies. Arch Toxicol 2012;86(7):1137-51
59. Bakand S, Hayes A, Winder C. An integrated in vitro approach for toxicity testing of airborne contaminants. J Toxicol Environ Health A 2007;70(19):1604-12
60. Barile FA. Principles of toxicology testing. CRC Press, Boca Raton; 2008
61. Allen CB. In vitro models for lung toxicology. In: Gardner DE, editor. Toxicology of the Lung. 4th edition. Taylor & Francis, Boca Raton; 2006. p. 107-50
62. Spielmann H, Grune B, Liebsch M, et al. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment). Exp Toxicol Pathol 2008;60(2-3):225-33
63. Joeng L, Hayes A, Bakand S. Validation of the dynamic direct exposure method for toxicity testing of diesel exhaust in vitro. ISRN Toxicol 2013;2013:139512
64. Lestari F, Hayes AJ, Green AR, et al. In vitro cytotoxicity and morphological assessment of smoke from polymer combustion in human lung derived cells (A549). Int J Hyg Environ Health 2012;215(3):320-32
65. OECD. Acute Inhalation Toxicity, OECD, 403. 2009. Availble from http://www.oecd-library.org/environment/test-no-403-Acuteinhalation-toxicity- 9789264070608-en [Last accessed 7 November 2013]
66. OECD. Subchronic inhalation toxicity: 28-day study. OECD 412. 2009. Available from: http://www.oecdilibrary. org/environment/test-no-412-subacute- inhalation-toxicity-28-daystudy-9789264070783-en [Last accessed 7 November 2013]
67. OECD. Subchronic inhalation toxicity: 90-day study. OECD, 413. 2009. Available from: http://www.oecdilibrary. org/environment/test-no-413-subchronic- inhalation-toxicity-90-daystudy-9789264070806-en [Last accessed 7 November 2013]
68. OECD. Acute inhalation toxicity -Acute toxic class method. OECD, 436. 2009. Available from: http://www.oecdilibrary. org/environment/test-no-436- Acute-inhalation-toxicity-Acute-toxic-classmethod-9789264076037-en [Last accessed 7 November 2013]
69. OECD. Guidance document on acute inhalation toxicity testing -series on testing and assessment number 39 [ENV/JM/MONO(2009)28]. 2009. Available from: http://iccvam. niehs.nih.gov/SuppDocs/FedDocs/OECD/OECD-GD39.pdf [Last accessed 7 November 2013]
70. OECD. Guidance document on histopathology for inhalation toxicity studies, supporting TG 412 (subacute inhalation toxicity: 28-day study) and TG 413 (subchronic inhalation toxicity: 90-day study) [ENV/JM/MONO(2010) 16]. 2009. Available from: http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECD-GD125. pdf [Last accessed 7 November 2013]
71. Pauluhn J. Issues of dosimetry in inhalation toxicity. Toxicol Lett 2003;140-141:229-38
72. Phalen RF. Methods in inhalation toxicology. CRC Press, Boca Raton; 1997
73. Hayes A, Bakand S, Winder C. Novel in vitro exposure techniques for toxicity testing and biomonitoring of airborne contaminants. In: Marx U, Sandig V, editors. Drug testing in vitrobreakthroughs and trends in cell culture technology. Wiley-VCH, Berlin; 2007. p. 103-24
74. Pauluhn J. Overview of testing methods used in inhalation toxicity: from facts to artifacts. Toxicol Lett 2003;140-141:183-93
75. Blaauboer BJ. The applicability of in vitro-derived data in hazard identification and characterisation of chemicals. Environ Toxicol Pharmacol 2002;11(3-4):213-25
76. Gad SC. In vitro toxicology. Taylor and Francis, New York; 2000
77. Vogel R. Foreword: congress on alternative test methods in inhalation toxicology. Exp Toxicol Pathol 2008;60(2-3):97
78. Aufderheide M, Halter B, Mohle N, et al. The CULTEX RFS: A comprehensive technical approach for the in vitro exposure of airway epithelial cells to the particulate matter at the airliquid interface. Biomed Res Int 2013;2013:734137
79. ICCVAM. Report of the international workshop on in vitro methods for assessing acute systemic toxicity: Interagency Coordinating Committee on the Validation of Alternative Methods 2001
80. Anderson D, Russell T. The status of alternative methods in toxicology. 1st edition. The Royal Society of Chemistry, Cambridge; 1995
81. Bakand S, Winder C, Hayes A. Comparative in vitro cytotoxicity assessment of selected gaseous compounds in human alveolar epithelial cells. Toxicol In Vitro 2007;21(7):1341-7
82. Balls M, Fentem JH. The use of basal cytotoxicity and target organ toxicity tests in hazard identification and risk assessment. Altern Lab Anim 1992;20:368-88
83. Freshney IR. Culture of animal cells-A manual of basic techniques. 4th edition. John Wiley & Sons, Inc, New York; 2000
84. Driscoll KE. Cytokines and regulation of pulmonary inflammation. In: Gardner DE, Crapo JD, McClellan RO, editors. Toxicology of the Lung. Taylor & Francis, Philadelphia; 1999. p. 149-72
85. Stone V, Barlow PG, Hutchison GR, et al. Proinflammatory effects of particles on macrophages and epithelial cells. In: Donaldson K, Borm P, editors. Particle toxicology. CRC Press, Boca Raton; 2007. p. 183-96
86. Wallaert B, Gosset P, Boitelle A, et al. In vitro assessment of environmental toxicology using alveolar cells as target. Cell Biol Toxicol 1996;12(4-6):251-6
87. Huang S, Constant S. A long shelf-life in vitro cell model of the human airway epithelium (MucilairTM) for inhalation toxicity assessment. ZEBET Seminar. ZEBET, Berlin; 2009
88. Lazarovici P, Li M, Perets A, et al. Intelligent biomatrices and engineered tissue constructs: in-vitro models for drug discovery and toxicity testing. In: Marx U, Sandig V, editors. Drug testing in vitro-breakthroughs and trends in cell culture technology. Wiley-VCH, Berlin; 2007. p. 3-51
89. Mondrinos MJ, Koutzaki S, Jiwanmall E, et al. Engineering three-dimensional pulmonary tissue constructs. Tissue Eng 2006;12(4):717-28
90. Mondrinos MJ, Koutzaki S, Lelkes PI, et al. A tissue-engineered model of fetal distal lung tissue. Am J Physiol Lung Cell Mol Physiol 2007;293(3):L639-50
91. Ritter D, Knebel JW, Aufderheide M. In vitro exposure of isolated cells to native gaseous compounds -development and validation of an optimized system for human lung cells. Exp Toxicol Pathol 2001;53(5):373-86
92. Tu B, Wallin A, Moldeus P, et al. Cytotoxicity of NO2 gas to cultured human and murine cells in an inverted monolayer exposure system. Toxicology 1995;96(1):7-18
93. Bakand S, Winder C, Khalil C, et al. A novel in vitro exposure technique for toxicity testing of selected volatile organic compounds. J Environ Monit 2006;8(1):100-5
94. Bakand S, Winder C, Khalil C, et al. An experimental in vitro model for dynamic direct exposure of human cells to airborne contaminants. Toxicol Lett 2006;165(1):1-10
95. Aufderheide M. Direct exposure methods for testing native atmospheres. Exp Toxicol Pathol 2005;57(Suppl 1):213-26
96. Chen LC, Fang CP, Qu QS, et al. A novel system for the in vitro exposure of pulmonary cells to acid sulfate aerosols. Fundam Appl Toxicol 1993;20(2):170-6
97. Knebel JW, Ritter D, Aufderheide M. Development of an in vitro system for studying effects of native and photochemically transformed gaseous compounds using an air/liquid culture technique. Toxicol Lett 1998;96-97:1-11
98. Lang DS, Jorres RA, Mucke M, et al. Interactions between human bronchoepithelial cells and lung fibroblasts after ozone exposure in vitro. Toxicol Lett 1998;96-97:13-24
99. Potera C. More human, more humane: A new approach for testing airborne pollutants. Environ Health Perspect 2007;115(3):A148-51
100. Gerde P. How do we compare dose to cells in vitro with dose to live animals and humans? Some experiences with inhaled substances. Exp Toxicol Pathol 2008;60(2-3):181-4
101. Aufderheide M, Knebel JW, Ritter D. Novel approaches for studying pulmonary toxicity in vitro. Toxicol Lett 2003;140-141:205-11
102. Aufderheide M, Mohr U. A modified CULTEX system for the direct exposure of bacteria to inhalable substances. Exp Toxicol Pathol 2004;55(6):451-4
103. Knebel JW, Ritter D, Aufderheide M. Exposure of human lung cells to native diesel motor exhaust -development of an optimized in vitro test strategy. Toxicol In Vitro 2002;16(2):185-92
104. Aufderheide M, Knebel JW, Ritter D. An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke. Exp Toxicol Pathol 2003;55(1):51-7
105. Lestari F, Green AR, Chattopadhyay G, et al. An alternative method for fire smoke toxicity assessment using human lung cells. Fire Saf J 2006;41:605-15
106. Lestari F, Markovic B, Green AR, et al. Comparative assessment of three in vitro exposure methods for combustion toxicity. J Appl Toxicol 2006;26(2):99-114
107. Hohenegger M. Novel and current treatment concepts using pulmonary drug delivery. Curr Pharm Des 2010;16(22):2484-92
108. Wanakule P, Liu GW, Fleury AT, et al. Nano-inside-micro: disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung. J Control Release 2012;162(2):429-37
109. Vega-Villa KR, Takemoto JK, Yanez JA, et al. Clinical toxicities of nanocarrier systems. Adv Drug Deliv Rev 2008;60(8):929-38
110. Bakand S, Hayes A, Dechsakulthorn F. Nanoparticles: A review of particle toxicology following inhalation exposure. Inhal Toxicol 2012;24(2):125-35
111. Brunner TJ, Wick P, Manser P, et al. In vitro cytotoxicity of oxides nanoparticles: comparison to asbestos, silical, and the effects of particle solubility. Environ Sci Technol 2006;40:4374-81
112. Dechsakulthorn F, Hayes A, Bakand S, et al. In vitro cytotoxicity of selected nanoparticles using human skin fibroblasts. AATEX 2008;14(Special Issue):397-400
113. Donaldson K, Stone V, Tran CL, et al. Nanotoxicology. Occup Environ Med 2004;61(9):727-8
114. Donaldson K, Tran L, Jimenez LA, et al. Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Part Fibre Toxicol 2005;2:10
115. Gojova A, Guo B, Kota RS, et al. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect 2007;115(3):403-9
116. Nel A, Xia T, Madler L, et al. Toxic potential of materials at the nanolevel. Science 2006;311(5761):622-7
117. Renwick LC, Brown D, Clouter A, et al. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med 2004;61(5):442-7
118. Warheit DB. Nanoparticles health impacts. Mater Today 2004;7:32-5
119. Choi JY, Ramachandran G, Kandlikar M. The impact of toxicity testing costs on nanomaterial regulation. Environ Sci Technol 2009;43(9):3030-4
120. Karn B, Masciangioli T, Zhang W, et al. editors. Nanotechnology and the environment: Applications and implications. American Chemical Society, Washington, DC; 2005
121. Liu WT. Nanoparticles and their biological and environmental applications. J Biosci Bioeng 2006;102(1):1-7
122. Seaton A. Nanotechnology and the occupational physician. Occup Med (Lond) 2006;56(5):312-16
123. Tolstoshev A. Nanotechnology, assessing the environmental risks for Australia. Earth Policy Centre, University of Melbourne, Australia; 2006
124. Tippe A, Heinzmann U, Roth C. Deposition of fine and ultrafine aerosol particles during exposure at the air/cell interface. J Aerosol Sci 2002;33:207-18
125. Bitterle E, Karg E, Schroeppel A, et al. Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles. Chemosphere 2006;65(10):1784-90
126. Mulhopt S, Diabate S, Krebs T, et al. Lung toxicity determination by in vitro exposure at the air liquid interface with an integrated online dose measurement. J Phys 2009;170:1 Conference Series (170, 012008)
127. Drobne D. Nanotoxicology for safe and sustainable nanotechnology. Arh Hig Rada Toksikol 2007;58(4):471-8
128. Englert BC. Nanomaterials and the environment: uses, methods and measurement. J Environ Monit 2007;9:1154-61
129. Karlson HL, Cronholm P, Gustafsson J, et al. Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 2008;21:1726-32